# PRME (Prime Medicine, Inc.) - SEC EDGAR Financial Statements

> Prime Medicine, Inc. reported $4.63M in revenue and a net loss of $176.4M for the fiscal year ended December 31, 2025 (up 55.3% year over year), with a -3939.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/PRME
- Markdown: https://convexityos.com/fundamentals/PRME.md
- SEC CIK: 0001894562
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001894562&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $4.63M | +55.3% YoY |
| Operating Income | FY 2025 | -$182.5M | -3939.4% margin |
| Net Income | FY 2025 | -$176.4M | -3807.3% net margin |
| Diluted EPS | FY 2025 | -$0.99 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$158.5M | -3422.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $61.16M | Total debt: $110.4M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.63M | $2.98M | $0 | $0 | $0 | $5.21M |
| Research & Development | $160.6M | $155.3M | $147.9M | $86.72M | $70.55M | $2.98M |
| Total Operating Expenses | $213.0M | $205.4M | $204.8M | $116.5M | $84.47M | $6.14M |
| **Operating Income** | -$208.3M | -$202.5M | -$204.8M | -$116.5M | -$84.47M | -$932K |
| **EBITDA** | -$201.0M | -$196.3M | -$200.1M | -$114.3M | -$83.91M | -$889K |
| Interest Income | $4.15M | $3.52M | $2.81M | -- | -- | -- |
| Income Tax Expense | $0 | $0 | -$279K | -$948K | -$486K | $1.87M |
| **Net Income** | -$201.1M | -$195.9M | -$198.1M | -$121.8M | -$165.4M | -$3.41M |
| Basic EPS | -$1.35 | -$1.65 | -$2.18 | -$4.19 | -$14.19 | -$1.91 |
| **Diluted EPS** | -$1.35 | -$1.65 | -$2.18 | -$4.19 | -$14.19 | -$1.91 |
| Basic Shares Outstanding | 148.8M | 118.6M | 91.0M | 33.9M | 13.0M | 2.6M |
| Diluted Shares Outstanding | 148.8M | 118.6M | 91.0M | 33.9M | 13.0M | 2.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.21M | -- | -- | $838K | $1.23M | $1.11M | $1.45M | $2.18M |
| Research & Development | $34.12M | $33.40M | $34.10M | $34.71M | $43.99M | $41.38M | $40.56M | $34.10M |
| Total Operating Expenses | $44.14M | $44.44M | $51.51M | $49.45M | $55.20M | $54.49M | $53.85M | $46.41M |
| **Operating Income** | -$39.93M | -$43.28M | -$50.65M | -$48.61M | -$53.97M | -$53.38M | -$52.39M | -$44.22M |
| **EBITDA** | -$38.17M | -$41.50M | -$48.80M | -$46.73M | -$52.09M | -$51.51M | -$50.69M | -$42.51M |
| Interest Income | $555K | $788K | $1.02M | $1.08M | $1.14M | $743K | $1.18M | $1.54M |
| Income Tax Expense | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Net Income** | -$39.04M | -$42.11M | -$49.12M | -$46.08M | -$50.58M | -$52.59M | -$51.89M | -$42.28M |
| Basic EPS | -$0.22 | -$0.24 | -$0.28 | -- | -$0.32 | -$0.41 | -$0.40 | -- |
| **Diluted EPS** | -$0.22 | -$0.24 | -$0.28 | -- | -$0.32 | -$0.41 | -$0.40 | -- |
| Basic Shares Outstanding | 177.9M | 177.2M | 177.1M | -- | 160.5M | 129.2M | 130.9M | -- |
| Diluted Shares Outstanding | 177.9M | 177.2M | 177.1M | -- | 160.5M | 129.2M | 130.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $63.03M | $182.5M | $41.57M | $187.6M | $185.4M |
| Short-Term Investments | $114.6M | -- | -- | $98.47M | $68.24M |
| **Cash & Short-Term Investments** | $177.7M | $190.4M | $121.7M | $293.9M | $253.7M |
| Other Current Assets | $674K | $14.67M | $2.25M | $246K | -- |
| **Total Current Assets** | $181.3M | $211.9M | $143.0M | $296.6M | $270.6M |
| Property, Plant & Equipment, Net | $20.57M | $24.40M | $22.66M | $19.01M | $4.93M |
| Other Non-Current Assets | $1.00M | $0 | $779K | $1.65M | $2.47M |
| **Total Non-Current Assets** | $161.4M | $85.62M | $50.88M | $63.70M | $31.28M |
| **Total Assets** | $342.7M | $297.5M | $193.9M | $360.3M | $301.9M |
| Accounts Payable | $8.89M | $11.35M | $19.54M | $4.33M | $1.44M |
| Deferred Revenue (Current) | $7.82M | $7.09M | $0 | -- | -- |
| **Total Current Liabilities** | $37.45M | $37.96M | $56.42M | $26.71M | $57.98M |
| Deferred Revenue (Non-Current) | $58.13M | $63.22M | $0 | -- | -- |
| **Total Non-Current Liabilities** | $184.4M | $106.4M | $4.36M | $17.33M | $4.31M |
| **Total Liabilities** | $221.9M | $144.4M | $60.78M | $44.04M | $62.30M |
| **Total Debt (incl. Leases)** | $116.4M | $40.79M | $13.63M | $28.75M | $10.41M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $0 |
| Retained Earnings | -$888.4M | -$687.2M | -$491.3M | -$293.2M | -$171.4M |
| Accumulated Other Comp. Income | $82K | $1.0K | -$15K | -$384K | -$27K |
| **Total Stockholders' Equity** | $120.9M | $153.1M | $133.1M | $316.3M | -$156.2M |
| Total Equity | $120.9M | $153.1M | $133.1M | $316.3M | -$156.2M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $54.89M | $47.45M | $64.11M | $63.03M | $71.40M | $53.80M | $91.88M | $182.5M |
| Short-Term Investments | $6.27M | $47.62M | $71.39M | $114.6M | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $61.20M | $95.10M | $135.5M | $177.7M | $213.3M | $101.8M | $144.3M | $190.4M |
| Other Current Assets | -- | $376K | $421K | $674K | $15.63M | $16.39M | $16.54M | $14.67M |
| **Total Current Assets** | $63.69M | $96.80M | $137.9M | $181.3M | $231.4M | $121.3M | $163.8M | $211.9M |
| Property, Plant & Equipment, Net | $15.62M | $17.08M | $18.82M | $20.57M | $22.05M | $23.83M | $24.96M | $24.40M |
| Other Non-Current Assets | $3.28M | $1.00M | $1.00M | $1.00M | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $150.2M | $152.2M | $156.8M | $161.4M | $153.6M | $157.7M | $164.4M | $85.62M |
| **Total Assets** | $213.9M | $249.0M | $294.7M | $342.7M | $385.0M | $279.0M | $328.2M | $297.5M |
| Accounts Payable | $6.39M | $5.81M | $12.32M | $8.89M | $9.35M | $6.38M | $10.03M | $11.35M |
| Deferred Revenue (Current) | $8.98M | $7.93M | $7.32M | $7.82M | $6.95M | $8.31M | $8.21M | $7.09M |
| **Total Current Liabilities** | $35.63M | $31.69M | $36.29M | $37.45M | $35.02M | $34.11M | $34.29M | $37.96M |
| Deferred Revenue (Non-Current) | $50.78M | $56.03M | $57.77M | $58.13M | $59.75M | $59.56M | $60.66M | $63.22M |
| **Total Non-Current Liabilities** | $169.8M | $177.5M | $181.7M | $184.4M | $188.2M | $184.0M | $187.0M | $106.4M |
| **Total Liabilities** | $205.4M | $209.2M | $218.0M | $221.9M | $223.2M | $218.1M | $221.2M | $144.4M |
| **Total Debt (incl. Leases)** | $110.4M | $112.5M | $114.5M | $116.4M | $118.1M | $119.7M | $121.2M | $40.79M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$1.02B | -$979.6M | -$937.5M | -$888.4M | -$842.3M | -$791.7M | -$739.1M | -$687.2M |
| Accumulated Other Comp. Income | -$3.0K | -$9.0K | -$1.0K | $82K | $33K | -$10K | -$15K | $1.0K |
| **Total Stockholders' Equity** | $8.44M | $39.81M | $76.70M | $120.9M | $161.8M | $60.86M | $106.9M | $153.1M |
| Total Equity | $8.44M | $39.81M | $76.70M | $120.9M | $161.8M | $60.86M | $106.9M | $153.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$201.1M | -$195.9M | -$198.1M | -$121.8M | -$165.4M | -$3.41M |
| Depreciation & Amortization | $7.32M | $6.13M | $4.65M | $2.22M | $568K | $43K |
| Stock-Based Compensation | $29.27M | $26.07M | $13.91M | $6.46M | $1.75M | $391K |
| Change in Payables | $996K | -$5.26M | $9.14M | $2.46M | $1.19M | $250K |
| **Operating Cash Flow** | -$162.6M | -$122.9M | -$165.4M | -$131.8M | -$34.08M | -$5.54M |
| Capital Expenditure | -$4.53M | -$7.29M | -$8.72M | -$16.09M | -$4.15M | -$639K |
| **Free Cash Flow** | -$167.1M | -$130.2M | -$174.1M | -$147.9M | -$38.23M | -$6.18M |
| **Investing Cash Flow** | -$108.8M | $68.46M | $18.71M | -$47.10M | -$73.63M | -$1.06M |
| Common Stock Issued | $0 | $38.08M | $0 | -- | -- | -- |
| **Financing Cash Flow** | $151.5M | $195.9M | $655K | $181.5M | $269.3M | $34.93M |
| **Net Change in Cash** | -$119.8M | $141.5M | -$146.0M | $2.57M | $161.6M | $28.33M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$39.04M | -$42.11M | -$49.12M | -$46.08M | -$50.58M | -$52.59M | -$51.89M | -$42.28M |
| Depreciation & Amortization | $1.76M | $1.78M | $1.86M | $1.88M | $1.88M | $1.86M | $1.70M | $1.72M |
| Stock-Based Compensation | $4.80M | $4.87M | $4.64M | $4.51M | $12.75M | $6.33M | $5.68M | $5.94M |
| Change in Receivables | -- | $0 | $0 | -- | $120K | -$103K | -$17K | -- |
| Change in Payables | $586K | -$6.52M | $3.55M | -$581K | $3.04M | -$3.35M | $1.88M | $2.46M |
| **Operating Cash Flow** | -$36.68M | -$41.05M | -$42.71M | -$37.26M | -$35.04M | -$41.41M | -$48.86M | $16.25M |
| Capital Expenditure | -$298K | -$46K | -$214K | -$290K | -$247K | -$1.57M | -$2.42M | -$1.79M |
| **Free Cash Flow** | -$36.98M | -$41.09M | -$42.92M | -$37.55M | -$35.29M | -$42.98M | -$51.28M | $14.45M |
| **Investing Cash Flow** | $41.25M | $24.03M | $43.39M | $28.33M | -$92.12M | $2.77M | -$47.74M | $48.25M |
| **Financing Cash Flow** | $2.87M | $361K | $393K | $562K | $144.8M | $197K | $6.00M | $1.0K |
| **Net Change in Cash** | $7.43M | -$16.66M | $1.07M | -$8.36M | $17.59M | -$38.44M | -$90.60M | $64.50M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -4498.1% | -6787.4% | -- | -- | -- | -17.9% |
| **Net Profit Margin** | -4342.4% | -6566.6% | -- | -- | -- | -65.5% |
| Return on Equity (ROE) | -166.4% | -127.9% | -148.9% | -38.5% | -- | -- |
| Return on Assets (ROA) | -58.7% | -65.8% | -102.2% | -33.8% | -54.8% | -- |
| Current Ratio | 4.84x | 5.58x | 2.53x | 11.10x | 4.67x | -- |
| Quick Ratio | 4.75x | 5.02x | 2.16x | 11.00x | 4.37x | -- |
| Debt to Equity | 0.96x | 0.27x | 0.10x | 0.09x | -- | -- |
| **Revenue Growth (YoY)** | +55.3% | -- | -- | -- | -100.0% | -- |
| 5Y Revenue / Share Growth | -98.4% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -4498.1% | -3412.5% | -4116.6% | -5369.7% | -6787.4% |
| **Net Profit Margin** | -- | -- | -- | -4342.4% | -3301.6% | -4016.8% | -5252.5% | -6566.6% |
| Return on Equity (ROE) | -2090.2% | -472.0% | -258.6% | -166.4% | -121.9% | -327.4% | -188.9% | -127.9% |
| Return on Assets (ROA) | -82.5% | -75.4% | -67.3% | -58.7% | -51.3% | -71.4% | -61.6% | -65.8% |
| Current Ratio | 1.79x | 3.05x | 3.80x | 4.84x | 6.61x | 3.56x | 4.78x | 5.58x |
| Quick Ratio | 1.72x | 3.00x | 3.73x | 4.75x | 6.09x | 2.98x | 4.21x | 5.02x |
| Debt to Equity | 13.09x | 2.83x | 1.49x | 0.96x | 0.73x | 1.97x | 1.13x | 0.27x |
| **Revenue Growth (YoY)** | +243.9% | -- | -- | -61.6% | +486.1% | -- | +146.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -329.3% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -359.8% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
